OCUL – ocular therapeutix, inc. (US:NASDAQ)

News

Ocular Therapeutix™ to Present Additional SOL-1 Data and Analyses at Upcoming Scientific Conferences in April
Here is Why Ocular Therapeutix (OCUL) is Highly Favored by Hedge Funds [Yahoo! Finance]
Ocular Therapeutix Touts Landmark Phase 3 AXPAXLI Win at RBC Ophthalmology Conference [Yahoo! Finance]
EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug [Yahoo! Finance Canada]
EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com